Smoore International announced on 21 October via its official LinkedIn account that it has officially launched its innovative skincare brand MOYAL in the US market. This marks a significant step for the company as it expands its product offering beyond vaping technology and into the skincare industry.
The brand's product range is reportedly currently only sold through its official website in the US, with its flagship LOOM vaporizer priced at $699. 2Firsts has learned that MOYAL was launched in the domestic market on 28 February this year. According to the MOYAL Tmall flagship store, the LOOM vaporizer device is currently priced at 5239 yuan (approximately $735) in China, slightly higher than the price listed on the official US website.
MOYAL's official entry into the American market was simultaneously announced on the brand's major international social media platforms, including Instagram, Facebook and Tiktok. However, the brand's international social media promotion is still in its early stages.
Furthermore, Smoore's LinkedIn page reveals that the brand's flagship product is the LOOM range, a skincare atomiser that is currently in the patent process. It is claimed to "allow the essence to penetrate deeper into the skin, avoiding invasive treatments and side effects".
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
